(Q24806894)

English

ELITE II and Val-HeFT are different trials: together what do they tell us?

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

ELITE II and Val-HeFT are different trials: together what do they tell us? (English)

0 references

1

Kenneth Dickstein

0 references

language of work or name

1 reference

2001

0 references

published in

Current controlled trials in cardiovascular medicine

1 reference

stated in

PubMed

volume

2

0 references

issue

5

0 references

page(s)

240-243

0 references

cites work

Noninferiority trials

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

7 April 2017

Angiotensin II type 1 receptor blockers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

28 September 2017

European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

28 September 2017

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

28 September 2017

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

28 September 2017

National Hospital Discharge Survey: annual summary, 1993.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

30 May 2018

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

28 November 2018

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

28 November 2018

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=59523

retrieved

28 November 2018

Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11806803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11806803

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/CVM-2-5-240

0 references

Dimensions Publication ID

1052053238

0 references

PMC publication ID

59523

0 references

PubMed publication ID

11806803

0 references

ResearchGate publication ID

11552036

0 references

(Q24806894)

ELITE II and Val-HeFT are different trials: together what do they tell us?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)